(MENAFN- GetNews)


"The global Single-Use Bioreactors (SUBs) Market is projected to grow from USD 4.4 billion in 2024 to USD 9.1 billion by 2029, at a CAGR of 15.4%."Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029

Market growth is driven by the increasing adoption of single-use technologies among SMEs, CDMOs, and CMOs, along with the advantages of SUBs over traditional stainless-steel systems. These include lower capital costs, reduced water and energy usage, and greater flexibility .

However, issues such as leachables and extractables , regulatory challenges , and PFAS restrictions may limit growth. Despite these challenges, the development of hybrid facilities -which combine traditional and single-use systems-presents strong opportunities for cost efficiency and flexibility.

Download PDF Brochure:

A key concern for manufacturers remains the risk of bag breakage , which can cause contamination and financial losses.

In 2023, single-use bioreactor systems and stirred-tank bioreactors dominated the market. North America led globally, supported by a strong biopharmaceutical R&D presence.

Major players include Sartorius AG , Danaher Corporation , Thermo Fisher Scientific Inc. , and Merck KGaA .

Key Players

Sartorius AG – Leading Provider of Single-Use Bioreactor Solutions Sartorius AG serves biopharmaceutical and pharmaceutical companies, CMOs, and CROs with a wide portfolio of high-quality, technology-driven SUB solutions . Strong R&D investments and global expansion have strengthened its market position, driving continued growth in the single-use bioreactors sector.

Danaher Corporation – Innovator in Bioprocessing Technologies Through its subsidiary Cytiva , Danaher offers advanced solutions for cell culture, filtration, separation, and purification . Its single-use bioreactor technologies play a key role in drug, plasma, and vaccine production , making it a major force in the market.

Thermo Fisher Scientific Inc. – Comprehensive Single-Use Solutions Provider Thermo Fisher offers an extensive range of single-use bioreactor products addressing diverse bioprocessing needs. Backed by strong market presence and R&D investments, the company continues to drive innovation and meet evolving industry demands.

Market Segmentation Insights

By Product:

• Single-use bioreactor systems lead the market due to lower setup costs, reduced operational complexity, and eco-friendly recyclable components.

By Type:

• Stirred-tank bioreactors hold the largest share, valued for their scalability, versatility, and efficient gas/nutrient distribution-ideal for producing vaccines, recombinant proteins, and monoclonal antibodies.

By Molecule Type:

• Monoclonal antibodies (mAbs) dominate, driven by expanding cancer therapies and R&D pipelines.

By Cell Type:

• Mammalian cells remain the most widely used due to their complex metabolic capabilities essential for biologics production.

By Application:

• Bioproduction leads, supported by increasing biopharmaceutical approvals, biosimilar growth, and the expiration of major drug patents.

By End User:

• Pharmaceutical and biotechnology companies represent the largest user segment, attributed to heightened R&D activity and biologics production.

Regional Analysis

• North America : Largest market share, supported by strong biopharma infrastructure and personalized medicine growth.
• Europe : Significant market presence with increasing biologics adoption.
• Asia Pacific : Expected to record the fastest growth , driven by rising biosimilar demand, expanding biomanufacturing capacity, and growth in contract manufacturing.

Key Takeaway

The single-use bioreactors market is witnessing rapid transformation as the biopharmaceutical industry embraces flexibility, scalability, and cost efficiency . With innovation from major players and strong R&D support, SUBs are set to play a pivotal role in the next generation of biologics manufacturing .

Request Sample Pages:

MENAFN14102025003238003268ID1110195821